News (102)

Transcript : Soleno Therapeutics, Inc. - Shareholder/Analyst Call
Ascendis Pharma Receives Positive CHMP Opinion for TransCon™ PTH (palopegteriparatide) for Adults with Chronic Hypoparathyroidism AQ
Soleno Therapeutics : Submission of Matters to a Vote of Security Holders - Form 8-K PU
SOLENO THERAPEUTICS INC : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
Transcript : Soleno Therapeutics, Inc. - Shareholder/Analyst Call
Nykode Therapeutics : Nomination Committee Proposal PU
Ascendis Pharma Submits Marketing Authorisation Application to the European Medicines Agency for TransCon PTH in Adult Patients with Hypoparathyroidism AQ
Transcript : Ascendis Pharma A/S - Special Call
Ascendis Pharma Submits Marketing Authorisation Application to the European Medicines Agency for TransCon™ PTH in Adult Patients with Hypoparathyroidism AQ
Transcript : Ascendis Pharma A/S, Q3 2022 Earnings Call, Nov 02, 2022
FDA Accepts for Priority Review Ascendis Pharma's NDA for TransCon PTH in Adult Patients with Hypoparathyroidism AQ
FDA Accepts for Priority Review Ascendis Pharma’s NDA for TransCon™ PTH in Adult Patients with Hypoparathyroidism AQ
Ascendis Pharma A/S : Notice to convene Extraordinary General Meeting - Form 6-K PU
Ascendis Pharma A/S Appoints Birgitte Volck as the Senior Vice President & Head of Clinical Development & Medical Affairs, Endocrinology Rare Diseases and Resigns from the Nominating and Corporate Governance Committee of the Company’S Board of Directors and Board of Directors CI
Vaccibody : Grant of Restricted Share Units and Share Options AQ
Transcript : Soleno Therapeutics, Inc. - Shareholder/Analyst Call
Vaccibody AS : appoints Dr. Volck, M.D., Ph.D. as new member of the Board AQ
Ascendis Pharma A/S : Election of Board Members 6. Election of State-authorized Public Auditor 7. Any proposals from the Board of Directors and/or Shareholders PU
AVROBIO : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) AQ
SOLENO THERAPEUTICS INC : Change in Directors or Principal Officers, Results of Operations and Financial Condition (form 8-K) AQ
AVROBIO : Reports 1Q 2020 Financial Results and Provides Business Update BU
AVROBIO : to Present New Clinical and Preclinical Data at Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, May 12-15, 2020 BU
Soleno Therapeutics, Inc. Announces Executive Changes CI
Transcript : AVROBIO, Inc. Presents at 16th Annual WORLDSymposium 2020, Feb-10-2020 through Feb-13-2020
AVROBIO : Announces Clinical Data Presentation and Multiple Events at WORLDSymposium 2020 AQ
AVROBIO : Announces Clinical Data Presentation and Multiple Events at WORLDSymposium™ 2020 BU
AVROBIO Announces Clinical Data Presentation and Multiple Events at WORLDSymposium™ 2020 CI
AVROBIO : Receives Orphan-Drug Designation from the U.S. FDA for AVR‑RD‑02 for the Treatment of Gaucher Disease BU
AVROBIO : Announces First Patient Dosed in Phase 1/2 Trial of Gene Therapy for Cystinosis BU
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2019 Financial Results GL
Transcript : AVROBIO, Inc. - Special Call
AVROBIO : Announces 87% Substrate Reduction in First Kidney Biopsy and Additional Positive Data from Clinical Trials of AVR-RD-01 Investigational Gene Therapy in Fabry Disease BU
Soleno Therapeutics Announces Appointment of Veteran Industry Executive Birgitte Volck, M.D., Ph.D., to Board of Directors GL
Soleno Therapeutics Appoints Birgitte Volck to its Board of Directors CI
AVROBIO : Highlights the plato™ Platform and Gaucher and Cystinosis Programs at the 2019 Annual Meeting of the American Society of Gene and Cell Therapy BU
AVROBIO, Inc. : Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update BU
Transcript : AVROBIO, Inc. - Shareholder/Analyst Call
AVROBIO : Announces Updated Clinical Data from Ongoing Phase 1 and Phase 2 Studies for AVR-RD-01 Gene Therapy for Fabry Disease PU
AVROBIO, Inc. : Announces Updated Clinical Data from Ongoing Phase 1 and Phase 2 Studies for AVR-RD-01 Gene Therapy for Fabry Disease BU
AVROBIO, Inc. Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GL
AVROBIO, Inc. Expands and Strengthens Leadership Team with Four Senior Management Hires GL
AVROBIO, Inc. Announces Management Changes CI
Wilson Therapeutics : Apr 11, 2018 Statement by the Independent Committee of the Board of Directors of Wilson Therapeutics in relation to the public offer from Alexion Read more PU
Wilson Therapeutics : Feb 21, 2018 Wilson Therapeutics AB (Publ) Year-End Report 2017 Read more PU
Wilson Therapeutics : Nov 23, 2017 Wilson Therapeutics AB (publ) Interim Report January 1–September 30, 2017 Read more PU
123NextSee all

Insiders

Picture Birgitte Volck
Birgitte Volck

Currently, Birgitte Volck holds the position of SVP, Head-Clinical Development & Medical Affairs at Ascendis Pharma A. Dr. Volck is also on the board of Soleno Therapeutics, Inc. and Vaccibody AS. Dr. Volck previously occupied the position of Head-Research & Development at GlaxoSmithKline Plc, Chief Medical Officer & Senior VP-Development at Swedish Orphan Biovitrum AB, President-Research & Development at Avrobio, Inc., Director-Executive Development at Amgen, Inc., Director-Nordic Medical & Project Director at Genzyme Danmark and Head-Clinical Development & Medical Affairs at Pharmexa A. Birgitte Volck received a doctorate from the University of Copenhagen.


Picture Birgitte Bonnesen
Birgitte Bonnesen

Birgitte Bonnesen served as the President & Chief Executive Officer at Swedbank AB from 2016 to 2019.
Prior to that, she worked at Swedbank AB for over 30 years.
Bonnesen holds an MBA from the Stockholm School of Economics and a graduate degree from the University of Aarhus.


Picture Birthe Volck Hybholt
Birthe Volck Hybholt

Birthe Volck Hybholt currently works as a Director at Videbæk Og Omegns Brugsforening.


Picture Birgitte Kolrud
Birgitte Kolrud

Ms. Birgitte Kolrud is on the Board of Directors at Nettpartner AS.
Ms. Kolrud was previously employed as a Senior Investment Manager by Norfund.



Picture Birgitte Hesselbjerg
Birgitte Hesselbjerg

Birgitte Hesselbjerg worked as a Director at Coop AmbA.









Picture Birgitte Nauntofte
Birgitte Nauntofte

Birgitte Nauntofte is currently the Vice Chairman at Steno Diabetes Center A, Director at The Danish Council For Research Policy, and a Member at Denmark Ministry of Education.
She was previously the Chief Executive Officer & Director at Novo Nordisk Fonden, Chairman at The Kennedy Collective Inc, Director at Danmarks Farmaceutiske Universitet, Professor-Clinical Oral Physiology at the University of Copenhagen, and a Member at Noregs forskingsråd and Denmark Ministry of Higher Edcation & Science.
She received her doctorate degree from the University of Copenhagen in 1993.






Picture Birgitte Olsen
Birgitte Olsen

Ms. Birgitte Olsen, CFA, is a Lead Portfolio Manager at Bellevue Asset Management AG.
She is also a Senior Portfolio Manager for European Equities.
She joined the firm in 2008.
She previously spent over nine years at Generali Investments in Cologne as Deputy Head of Equities, managing European portfolios and thematic funds.


Picture Birgitte Madsen
Birgitte Madsen

Birgitte Brinch Madsen is currently the Vice Chairman at DEIF A.
She also holds several non-executive director positions, including at John Wood Group Plc, Arkil Holding A, Investeringsforeningen Danske Invest, Investeringsforeningen Danske Invest Select, and Danske Invest Select.
Previously, she worked as the Director of Energy & Industry Business at COWI A and as the Chief Technical Officer at Maersk A and Maersk FPSOs A.
She graduated from the University of Copenhagen.





Picture Birgitte Hald
Birgitte Hald

Birgitte Hald is the founder of Nimbus Film ApS, where she holds the title of Chief Executive Officer & Partner since 1993.





Picture Birgitte Jeppesen
Birgitte Jeppesen

Birgitte Jeppesen has worked as a Director at Hornsyld Ejendomme.
AS since 2004.














Picture Birgitte Aas Gaarder
Birgitte Aas Gaarder

Birgitte Aas Gaarder worked as a Project Manager at Tjuvholmen KS.


Picture Birgitte Mabeck
Birgitte Mabeck

Birgitte Mabeck formerly worked at SAP SE, as Marketing Director-Europe, Middle East & Asia, Deltek Danmark A, as Marketing Director, Appian Graphics Corp., as Marketing Director-Europe, Middle East & Asia, Copenhagen Capacity, as Manager-Business Development, Thrane & Thrane A, as Head-Marketing, and SuccessFactors, Inc., as VP-Europe, Middle East & Asia Marketing.
Ms. Mabeck received her graduate degree from the University of Greenwich.








Picture Birgitte Svendsen
Birgitte Svendsen

Ms. Birgitte Svendsen is Chief Financial Officer at BioPorto A/S.





Picture Birgitte Stephensen
Birgitte Stephensen

Birgitte Stephensen is currently working as the Chief Legal Officer & Executive Vice President at Genmab A since 2002.
She graduated from Danmarks Farmaceutiske Universitet.




Picture Birgitte Nordvik
Birgitte Nordvik

Birgitte Nordvik is currently a Director at Data Design System AS.
Previously, she was a Director at Interwell AS.



Picture Birgitte Schytte
Birgitte Schytte

Birgitte Schytte currently works at Medicoindustrien, as Director.





Picture Birgitte Rono
Birgitte Rono

Birgitte Rono is currently working as the Chief Scientific Officer at Evaxion Biotech A.
She started this position in 2021.
In terms of education, Dr. Rono has an undergraduate and graduate degree from the University of Copenhagen.
She also holds a doctorate degree from Copenhagen University Hospital and the National Institutes of Health.


Picture Birgitte Kvalevåg Øversjøen
Birgitte Kvalevåg Øversjøen

Birgitte Kvalevåg Øversjøen has a current job as an Analyst at DNB Bank ASA (Broker).










Picture Birgitte Clausen
Birgitte Clausen

Birgitte Clausen currently works at Annebergs Limtræ A, as Director from 2022.





Picture Birgitte Lundeby Kolstad
Birgitte Lundeby Kolstad

Birgitte Lundeby Kolstad has worked as a Senior Associate at HitecVision Private Equity AS since 2020 and as a Senior Financial Analyst at Copenhagen Infrastructure Partners P since 2018.






Picture Birgitte Sand
Birgitte Sand

Birgitte Sand has a current job as a Director at Mindway AI ApS.


Picture Birgitte Karlsen
Birgitte Karlsen

Birgitte Karlsen formerly worked at Aker Offshore Wind AS, as General Counsel.
Ms. Karlsen received her graduate degree in 2002 from the University of Bergen.


Picture Birgitte Rønnow
Birgitte Rønnow

Birgitte Rønnow has founded Terranol A in 2007, where she currently holds the title of Chief Executive Officer.
She previously worked as a Principal at DuPont Nutrition Biosciences ApS.
Dr. Rønnow earned a doctorate degree from the University of Copenhagen in 1992.


















No results for this search